Title: Application of Artificial Intelligence in Targeted Protein Degrader Drug Discovery- Story of AnHorn Medicines

Speaker: Chu-Chiang Lin 林助強博士   安宏生醫創辦人兼董事長

Time: 18 Fri, Sep 29, 2023, 9:00 PM – 10:30 PM EDT

🔍 Discover AI’s Role in Modern Drug Development!
In 2023, Artificial Intelligence (AI) stands out as a groundbreaking technology. For biotech enthusiasts, the fusion of AI with drug development is a captivating evolution. Curious about how AI is revolutionizing new drug creation? Eager to delve into the advancements of Targeted Protein Degraders, the forefront of therapeutic modalities?

This September, we’re thrilled to host Dr. Chu-Chiang Lin, Founder and President of AnHorn Medicines. Dr. Lin will illuminate the journey of AnHorn Medicines in crafting an AI-centric platform and their strategy to pioneer the next wave of Targeted Protein Degraders.

Note: The session will be conducted in Mandarin. Upon successful registration, a confirmation email with the meeting link will be sent to you.

今年AI人工智慧掀起浪潮，在生技製藥領域的你，想了解如何人工智慧技術在新藥開發的應用嗎？想了解全球熱門的標靶蛋白降解藥 (Targeted Protein Degrader)之設計開發嗎?

本月榮幸邀請到資深藥物化學的專家，台灣安宏生醫創辦人林助強博士來分享自身豐富的藥物研發經驗，並談論如何結合兩大熱門領域人工智慧與蛋白降解藥物，為國家生技園區新創公司安宏生醫 (https://www.youtube.com/channel/UCbcVgv8LmDVPza_m4-gMVsw) 創立研發平台！